Is Hikma Pharmaceuticals PLC halal to invest in?

As of July 2026, Hikma Pharmaceuticals PLC HIK.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Hikma Pharmaceuticals PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hikma Pharmaceuticals PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Hikma Pharmaceuticals PLC?

Muslim investors may consider investing in Hikma Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Hikma Pharmaceuticals PLC classified as HALAL?

Musaffa determines the Shariah status of Hikma Pharmaceuticals PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Hikma Pharmaceuticals PLC updated?

The Shariah compliance status of Hikma Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Hikma Pharmaceuticals PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Hikma Pharmaceuticals PLC?

You can check the latest Shariah compliance status of Hikma Pharmaceuticals PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Hikma Pharmaceuticals PLC HIK.L

Last Updated: Jul 20, 12:00 AM·LSE

HIK.L Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Hikma Pharmaceuticals PLC is classified as halal.

HALAL

Report Source: 2025 Annual Report

Hikma Pharmaceuticals PLC. Stock Analysis HIK.L

United Kingdom Health Care Mid Cap Report: 2025 Annual

Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. The company supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). The company supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. The company supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.

Key Statistics of Hikma Pharmaceuticals PLC (HIK.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX1,521.00GBX1,566.00

Today's Open

GBX1,547.85

Volume

579.14K

P/E Ratio (TTM)

9.07

52 Week Range

GBX1,187.00GBX2,046.00

Market Cap

349.42B

Avg. Volume

458.53K

Dividend Yield

4.21%

Financial Metrics & Statements of Hikma Pharmaceuticals PLC (HIK.L)

Super Investors Invested in Hikma Pharmaceuticals PLC (HIK.L)

FAQ's for Hikma Pharmaceuticals PLC (HIK.L)

As of July 2026, Hikma Pharmaceuticals PLC HIK.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hikma Pharmaceuticals PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in Hikma Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Hikma Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Hikma Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Hikma Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.